Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR

Virology Journal

Volumn 1, Issue , 2004, Pages

  Finstad, Samantha L ^a   Prabhu, Sudha ^a   Rulli, Karen R ^a,b   Levy, Laura S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C MYB;

ARTICLE; BINDING SITE; GEL MOBILITY SHIFT ASSAY; GENE SEQUENCE; HEMATOPOIESIS; LONG TERMINAL REPEAT; ONCOGENE C MYB; PROTEIN BINDING; REPORTER GENE;

ANIMALS; CATS; CELL LINE, TUMOR; CREB-BINDING PROTEIN; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LEUKEMIA VIRUS, FELINE; MUTATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYB; TERMINAL REPEAT SEQUENCES; VIRUS REPLICATION;

EID: 10644248518     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-1-3     Document Type: Article

References (33)

1. Rohn JL, Gwynn SR, Lauring AS, Linenberger ML, Overbaugh J: Viral genetic variation, AIDS, and the multistep nature of carcinogenesis: the feline leukemia virus model. Leukemia 1996, 10(12):1867-1869.
2. Levy LS, Starkey CR, Prabhu S, Lobelle-Rich PA: Cooperating events in lymphomagenesis mediated by feline leukemia virus. Leukemia 1997, 11(Suppl 3):239-241.
3. Levesque KS, Bonham L, Levy LS: flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J Virol 1990, 64(7):3455-3462.
4. Athas GB, Choi B, Prabhu S, Lobelle-Rich PA, Levy LS: Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology 1995, 214(2):431-438.
5. Athas GB, Lobelle-Rich P, Levy LS: Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors. J Virol 1995, 69(6):3324-3332.
6. Lozzio BB, Lozzio CB, Bamberger EG, Feliu AS: A multipotential leukemia cell line (K562) of human origin. Proc Soc Exp Biol Med 1981, 166:546-550.
7. Burger SR, Zutter MM, Sturgill-Koszycki S, Santoro SA: Induced cell surface expression of functional alpha2beta1 integrin during megakaryocytic differentiation of K562 leukemic cells. Exp Cell Res 1992, 202:28-35.
8. Prabhu S, Lobelle-Rich PA, Levy LS: The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication. Virology 1999, 263(2):460-470.
9. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, et al.: Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998, 26(1):362-367.
10. Biedenkapp H, Borgmeyer U, Sippel AE, Klempnauer KH: Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 1988, 335(6193):835-837.
11. Ness SA, Marknell A, Graf T: The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 1989, 59(6):1115-1125.
12. Tanikawa J, Yasukawa T, Enari M, Ogata K, Nishimura Y, Ishii S, Sarai A: Recognition of specific DNA sequences by the c-myb protooncogene product: role of three repeat units in the DNA-binding domain. Proc Natl Acad Sci U S A 1993, 90(20):9320-9324.
13. Rosson D, O'Brien T: Constitutive c-myb expression in K-562 cells inhibits induced erythroid differentiation but not tetradecanoyl phorbol acetate-induced megakaryoctyic differentiation. Mol Cell Biol 1995, 15:772-779.
14. Ness SA: Myb binding proteins: regulators and cohorts in transformation. Oncogene 1999, 18(19):3039-3046.
15. Oh IH, Reddy EP: The myb gene family in cell growth, differentiation and apoptosis. Oncogene 1999, 18(19):3017-3033.
16. Guehmann S, Vorbrueggen G, Kalkbrenner F, Moelling K: Reduction of a conserved Cys is essential for Myb DNA-binding. Nucleic Acids Res 1992, 20(9):2279-2286.
17. Blobel GA: CBP and p300: versatile coregulators with important roles in hematopoietic gene expression. J Leukoc Biol 2002, 71(4):545-556.
18. Bosselut R, Lim F, Romond P, Frampton J, Brady J, Ghysdael J: Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression. Virology 1992, 186:764-769.
19. Dasgupta P, Reddy CD, Saikumar P, Reddy EP: The cellular protooncogene product Myb acts as transcriptional activator of the long terminal repeat of human T-lymphotropic virus type 1. J Virol 1992, 66(1):270-276.
20. Taylor D, Badiani P, Weston K: A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev 1996, 10(21):2732-2744.
21. Garcia A, LaMontagne K, Reavis D, Stober-Grasser U, Lipsick JS: Determinants of sequence-specific DNA-binding by p48vmyb. Oncogene 1991, 6(2):265-273.
22. Friedman AD: Transcriptional regulation of granulocyte and monocyte development. Oncogene 2002, 21(21):3377-3390.
23. Dasgupta P, Saikumar P, Reddy CD, Reddy EP: Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription. Proc Natl Acad Sci U S A 1990, 87(20):8090-8094.
24. Nieves A, Levy LS, Lenz J: Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3. J Virol 1997, 71(2):1213-1219.
25. Rulli K, Lenz J, Levy LS: Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus. J Virol 2002, 76(5):2363-2374.
26. Rojko JL, Hoover EA, Mathes LE, Hause WR, Schaller JP, Olsen RG: Detection of feline leukemia virus in tissues of cats by a paraffin embedding immunofluorescence procedure. J Natl Cancer Inst 1978, 61(5):1315-1321.
27. Rojko JL, Hoover EA, Mathes LE, Olsen RG, Schaller JP: Pathogenesis of experimental feline leukemia virus infection. J Natl Cancer Inst 1979, 63(3):759-768.
28. Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass CK: Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A 1997, 94(4):1074-1079.
29. Takahashi T, Suwabe N, Dai P, Yamamoto M, Ishii S, Nakano T: Inhibitory interaction of c-Myb and GATA-1 via transcriptional co-activator CBP. Oncogene 2000, 19(1):134-140.
30. Yamamoto H, Kihara-Negishi F, Yamada T, Suzuki M, Nakano T, Oikawa T: Interaction between the Hematopoietic Ets Transcription Factor Spi-B and the Coactivator CREB-binding Protein Associated with Negative Cross-talk with c-Myb. Cell Growth Differ 2002, 13(2):69-75.
31. Manabe N, Yamamoto H, Yamada T, Kihara-Negishi F, Hashimoto Y, Mochizuki M, Oikawa T: Prevention of PU.1-induced growth inhibition and apoptosis but not differentiation block in murine erythroleukemia cells by overexpression of CBP. Int J Oncol 2003, 22(6):1345-1350.
32. Rojko JL, Kociba GJ, Abkowitz JL, Hamilton KL, Hardy WD Jr, Ihle JN, O'Brien SJ: Feline lymphomas: immunological and cytochemical characterization. Cancer Res 1989, 49(2):345-351.
33. Donahue PR, Hoover EA, Beltz GA, Riedel N, Hirsch VM, Overbaugh J, Mullins JI: Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol 1988, 62(3):722-731.